Search - tctmd.com

Displaying 221 - 234 of 234

Sort: Relevancy | Date

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

Presentation ACC 2014

Stem Cells: Regenerate Failing Hearts - Results from the MSC-HF Trial

Presenter: Anders Bruun Mathiasen

March 31, 2014

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

L.A. McKeown

March 30, 2014

Presentation ACC 2014

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Presenter: Philippe Généreux

March 30, 2014

News Conference News ACC 2013

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Jason Kahn

March 09, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

Presentation ACC 2012

Drug-Eluting Balloons: Novel Technology and Applications

Presenter: Sigmund Silber

March 26, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

Presentation ACC 2012

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

Presenter: Emerson C. Perin

March 25, 2012

News Conference News ACC 2012

Stem Cell Therapy Fails to Show Benefit in Chronic Ischemic Heart Failure

L.A. McKeown

March 24, 2012

Presentation ACC 2012

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Presenter: Gennaro Sardella

March 24, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

Advertisement

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Stem Cells: Regenerate Failing Hearts - Results from the MSC-HF Trial

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Drug-Eluting Balloons: Novel Technology and Applications

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

Stem Cell Therapy Fails to Show Benefit in Chronic Ischemic Heart Failure

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content